Evidence map›Paper›PMID 32547028›Full record

ArticleInternational journal of nanomedicine2020

A Potent and Safer Anticancer and Antibacterial

Sona Sarli, Mohamad Reza Kalani, Abdolvahab Moradi

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Elucidation ofFrontiers in pharmacology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biosynthesis of Silver Nanoparticles Using Culture Supernatant ofInternational journal of nanomedicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Sona SarliDepartment of Chemistry, Arak Islamic Azad University, Arak, Iran.
Mohamad Reza Kalani *Medical Cellular and Molecular Research Center, School of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan, Iran.ORCID 0000-0002-8756-1200
Abdolvahab Moradi *Department of Microbiology, College of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Golestan University · IRGolestan University of Medical Sciences · IRIslamic Azad University, Arak · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePaclitaxel is a generic drug produced based on Taxol which is an extract of MATERIALS AND

methodsColloidal silver nanoparticles (AgNPs) were synthesized by reducing aqueous AgNO

resultsThis work proposes more anticancer effects for AgNP made by

conclusionThe production of herbal-mediated silver nanoparticles may be an efficient substitution for the silver nitrate-based medicines with less side effects.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsDynamic Light ScatteringEscherichia coliGreen Chemistry TechnologyHumansMCF-7 CellsMetal NanoparticlesMicrobial Sensitivity TestsParticle SizePlant ExtractsSilverStaphylococcus aureusTaxusAnti-Bacterial AgentsAntineoplastic AgentsPlant ExtractsSilverantibacterialanticancergreen synthesissilver nanoparticleTaxus tree extract

Identifiers

PMID32547028
PMCPMC7266392
OpenAlexW3029413091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.